Most recently, we reported upregulated plasma and tumor tissue expression of NRP-1 in breast cancer cases with advanced nodal and metastatic disease, and particularly in triple negative breast cancer compared to other molecular subtypes [4]. Here, NRP1 is linked to breast cancer.